Page last updated: 2024-11-07

1-amino-2-phenylethylphosphonic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-amino-2-phenylethylphosphonic acid (APPA) is a structural analog of the neurotransmitter dopamine, and it is known to inhibit the activity of dopamine transporter (DAT), a protein responsible for reuptake of dopamine in the brain. APPA has been investigated as a potential therapeutic agent for Parkinson's disease and other neurological disorders. Its synthesis involves the reaction of phosphorous acid with 2-phenylethylamine, leading to the formation of a phosphonic acid derivative with a chiral center. Studies have shown that APPA can effectively block DAT, thus increasing dopamine levels in the synapse. APPA has also been found to exhibit neuroprotective effects in animal models of Parkinson's disease. The compound's potential as a treatment for Parkinson's disease and other neurodegenerative disorders is being actively investigated.'
```

1-amino-2-phenylethylphosphonic acid: RN given refers to cpd without isomeric designation: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID97710
CHEMBL ID1090913
SCHEMBL ID2375608
MeSH IDM0134268

Synonyms (15)

Synonym
nsc-30080
6324-00-1
NSC30080 ,
NCI60_002524
phosphonic acid, (1-amino-2-phenylethyl)-
alpha-amino-beta-phenylethylphosphonic acid
nsc 30080
(1-amino-2-phenylethyl)phosphonic acid
1-amino-2-phenylethylphosphonic acid
OPREA1_662395 ,
CHEMBL1090913
SCHEMBL2375608
p-(1-amino-2-phenylethyl)phosphonic acid
DTXSID301273467
EN300-4252671
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (5)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Aminopeptidase NHomo sapiens (human)Ki27.50000.00081.956910.0000AID472441
Aminopeptidase NSus scrofa (pig)IC50 (µMol)54.00000.00053.53548.9000AID472434
Receptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)IC50 (µMol)223.00004.60004.60004.6000AID513950
Receptor-type tyrosine-protein phosphatase betaHomo sapiens (human)IC50 (µMol)139.00000.00000.00000.0000AID513951
Cytosol aminopeptidaseHomo sapiens (human)Ki0.42000.00060.16010.4200AID472440
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (14)

Processvia Protein(s)Taxonomy
angiogenesisAminopeptidase NHomo sapiens (human)
cell differentiationAminopeptidase NHomo sapiens (human)
symbiont entry into host cellAminopeptidase NHomo sapiens (human)
proteolysisAminopeptidase NHomo sapiens (human)
peptide catabolic processAminopeptidase NHomo sapiens (human)
integrin-mediated signaling pathwayReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
insulin receptor signaling pathwayReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
modulation of chemical synaptic transmissionReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
regulation of focal adhesion assemblyReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
protein dephosphorylationReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
protein dephosphorylationReceptor-type tyrosine-protein phosphatase betaHomo sapiens (human)
phosphate-containing compound metabolic processReceptor-type tyrosine-protein phosphatase betaHomo sapiens (human)
glial cell migrationReceptor-type tyrosine-protein phosphatase betaHomo sapiens (human)
dephosphorylationReceptor-type tyrosine-protein phosphatase betaHomo sapiens (human)
angiogenesisReceptor-type tyrosine-protein phosphatase betaHomo sapiens (human)
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activityReceptor-type tyrosine-protein phosphatase betaHomo sapiens (human)
proteolysisCytosol aminopeptidaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (15)

Processvia Protein(s)Taxonomy
virus receptor activityAminopeptidase NHomo sapiens (human)
aminopeptidase activityAminopeptidase NHomo sapiens (human)
metallopeptidase activityAminopeptidase NHomo sapiens (human)
signaling receptor activityAminopeptidase NHomo sapiens (human)
metalloaminopeptidase activityAminopeptidase NHomo sapiens (human)
zinc ion bindingAminopeptidase NHomo sapiens (human)
peptide bindingAminopeptidase NHomo sapiens (human)
protein tyrosine phosphatase activityReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
transmembrane receptor protein tyrosine phosphatase activityReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
protein bindingReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
transmembrane receptor protein tyrosine phosphatase activityReceptor-type tyrosine-protein phosphatase betaHomo sapiens (human)
protein bindingReceptor-type tyrosine-protein phosphatase betaHomo sapiens (human)
cadherin bindingReceptor-type tyrosine-protein phosphatase betaHomo sapiens (human)
aminopeptidase activityCytosol aminopeptidaseHomo sapiens (human)
carboxypeptidase activityCytosol aminopeptidaseHomo sapiens (human)
protein bindingCytosol aminopeptidaseHomo sapiens (human)
metalloexopeptidase activityCytosol aminopeptidaseHomo sapiens (human)
manganese ion bindingCytosol aminopeptidaseHomo sapiens (human)
metalloaminopeptidase activityCytosol aminopeptidaseHomo sapiens (human)
peptidase activityCytosol aminopeptidaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (17)

Processvia Protein(s)Taxonomy
extracellular spaceAminopeptidase NHomo sapiens (human)
lysosomal membraneAminopeptidase NHomo sapiens (human)
endoplasmic reticulum-Golgi intermediate compartmentAminopeptidase NHomo sapiens (human)
plasma membraneAminopeptidase NHomo sapiens (human)
external side of plasma membraneAminopeptidase NHomo sapiens (human)
secretory granule membraneAminopeptidase NHomo sapiens (human)
extracellular exosomeAminopeptidase NHomo sapiens (human)
cytoplasmAminopeptidase NHomo sapiens (human)
plasma membraneAminopeptidase NHomo sapiens (human)
extracellular spaceAminopeptidase NHomo sapiens (human)
plasma membraneReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
focal adhesionReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
membraneReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
extracellular exosomeReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
synaptic membraneReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
Schaffer collateral - CA1 synapseReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
receptor complexReceptor-type tyrosine-protein phosphatase alphaHomo sapiens (human)
plasma membraneReceptor-type tyrosine-protein phosphatase betaHomo sapiens (human)
specific granule membraneReceptor-type tyrosine-protein phosphatase betaHomo sapiens (human)
tertiary granule membraneReceptor-type tyrosine-protein phosphatase betaHomo sapiens (human)
receptor complexReceptor-type tyrosine-protein phosphatase betaHomo sapiens (human)
nucleusCytosol aminopeptidaseHomo sapiens (human)
trans-Golgi networkCytosol aminopeptidaseHomo sapiens (human)
focal adhesionCytosol aminopeptidaseHomo sapiens (human)
extracellular exosomeCytosol aminopeptidaseHomo sapiens (human)
cytoplasmCytosol aminopeptidaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID472441Inhibition of aminopeptidase N2010Bioorganic & medicinal chemistry, Apr-15, Volume: 18, Issue:8
New aromatic monoesters of alpha-aminoaralkylphosphonic acids as inhibitors of aminopeptidase N/CD13.
AID513949Effect on human cytoplasmic protein tyrosine phosphatase B assessed as change in enzyme activity at 100 uM at pH 52010Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
Identification of novel inhibitors for a low molecular weight protein tyrosine phosphatase via virtual screening.
AID513947Effect on human cytoplasmic protein tyrosine phosphatase A assessed as change in enzyme activity at 100 uM at pH 52010Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
Identification of novel inhibitors for a low molecular weight protein tyrosine phosphatase via virtual screening.
AID472434Inhibition of pig kidney aminopeptidase N using Leu-AMC as substrate2010Bioorganic & medicinal chemistry, Apr-15, Volume: 18, Issue:8
New aromatic monoesters of alpha-aminoaralkylphosphonic acids as inhibitors of aminopeptidase N/CD13.
AID513951Inhibition of human cytoplasmic protein tyrosine phosphatase B assessed as change in enzyme activity at pH 52010Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
Identification of novel inhibitors for a low molecular weight protein tyrosine phosphatase via virtual screening.
AID472440Inhibition of leucine aminopeptidase2010Bioorganic & medicinal chemistry, Apr-15, Volume: 18, Issue:8
New aromatic monoesters of alpha-aminoaralkylphosphonic acids as inhibitors of aminopeptidase N/CD13.
AID513950Inhibition of human cytoplasmic protein tyrosine phosphatase A assessed as change in enzyme activity at pH 52010Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
Identification of novel inhibitors for a low molecular weight protein tyrosine phosphatase via virtual screening.
AID513948Effect on human cytoplasmic protein tyrosine phosphatase A assessed as change in enzyme activity at 100 uM at pH 72010Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
Identification of novel inhibitors for a low molecular weight protein tyrosine phosphatase via virtual screening.
AID1224817Assays to identify small molecules inhibitory for eIF4E expression2015Chemistry & biology, Jul-23, Volume: 22, Issue:7
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (25.00)18.7374
1990's3 (37.50)18.2507
2000's0 (0.00)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.21 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.40 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (25.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (75.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]